OR WAIT null SECS
In this episode of Drug Digest, Pharmaceutical Technology editors discuss what happens in the manufacturing space from a CDMO and a cell/gene therapy perspective.
The biopharmaceutical industry has seen a lot of change in recent years, between new collaborations with supplier and contract development and manufacturing organizations (CDMOs) and accelerated drug delivery times. According to recent research, biopharmaceutical figures are already using digital and analytics for their benefit, with an increase of up to 40% in plant capacity, 20% in lead time, and 15% reduction in conversion costs (1).
With more growth comes more responsibilities, and processes like cell and gene therapy are on the forefront for the latest strategies to overcome the challenges in the manufacturing space.
Anil Kane has more than 25 years of experience in the science and business of taking molecules through the entire drug development process and currently serves as the global head of technical and scientific affairs, pharma services, Thermo Fisher Scientific. His extensive knowledge spans early-stage development to scale-up and commercial manufacturing and includes technical transfers between global sites and drug life cycle management.
Jason C. Foster has held leading roles in consulting, healthcare and technology companies for nearly 20 years in the US, UK and Europe. He also serves as a Non-Executive Director of London-based healthtech start-ups gripAble and Credentially, as well as Auxita Pty, an Australian healthcare data platform and hystrix medical AG, a Swiss B2B marketplace for medical products. As the Managing Director of Health Equity Consulting, he has advised private equity & venture capital funds, family offices, accelerators and healthTech start-ups.
This episode of Drug Digest is sponsored by:
Drug Digest is a tech talk video series with the Pharmaceutical Technology editors, who interview industry experts to discuss the emerging opportunities, obstacles, and advances in the pharmaceutical and biopharmaceutical industry for the research, development, formulation, analysis, upstream and downstream processing, manufacturing, supply chain, and packaging of drug products.